These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30076017)

  • 1. Routine indexes for cirrhosis and significant fibrosis detection in patients with compensated chronic hepatitis B.
    Zhang ZQ; Huang LW; Chen YP; Wang P
    Dig Liver Dis; 2019 Jan; 51(1):127-134. PubMed ID: 30076017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W; Li Y; Geng J; Wang P; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(49):e18038. PubMed ID: 31804310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
    Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
    J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP; Lu W; Zhang ZQ; Wang YB; Ding RR; Zhou XL; Huang D; Li XF
    J Viral Hepat; 2018 May; 25(5):581-589. PubMed ID: 29230907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
    Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
    Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
    Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
    Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
    Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
    J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.
    Wang J; Chen Z; Yan X; Yang Y; Liu Y; Chen Y; Jia B; Xia J; Xiong Y; Zhang Z; Ding W; Huang R; Wu C
    Discov Med; 2019 Sep; 28(153):149-158. PubMed ID: 31926586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Lang S; Kütting F; Staub A; Schramowski J; Schramm C; Kasper P; Goeser T; Steffen HM; Demir M
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1235-1240. PubMed ID: 28885276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B.
    Li Q; Lu C; Li W; Huang Y; Chen L
    Oncotarget; 2017 Jul; 8(28):45768-45776. PubMed ID: 28514753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B.
    Lee HW; Kang W; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park YN; Han KH
    Liver Int; 2016 Jan; 36(1):24-30. PubMed ID: 25966326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.